#Breaking: . @Synairgenplc has “completed” the first part of a trial which saw #coronavirus patients in hospital given #SNG001, according to its chief exec.

.@Synairgenplc has "completed" the first part of a trial which saw #coronavirus patients in hospital given SNG001, according to its chief exec.

The company claims the experimental drug prevented 79% of #COVID19 cases from progressing.#KayBurley live: https://t.co/nkEhmeDwMn pic.twitter.com/PIuazYKv0v

— SkyNews (@SkyNews) July 20, 2020

Source: Twitter